Roundtables
RWE4Decisions hosts invitation-only online roundtables, held under the Chatham House Rule, together with the Learning Network.
These expert discussions highlight practical applications of real-world evidence in HTA and Payer decision-making across Europe and North America, often through focused case studies.
Each roundtable brings together a wide range of stakeholders, including HTA bodies, payers, regulators, academia, patient representatives, registry holders, data experts, clinicians, and industry.
Below you can find reports that capture and summarise the key discussions and
insights from these roundtables.
March 24, 2025
Report
Roundtable Report: WHO Novel Medicines Platform draft guide principles for Managed Entry Agreement (20 February 2025)
September 12, 2024
Report
Roundtable Report: Post-Launch Evidence Generation (PLEG): Learnings from Italy, Germany, and the French DESCAR-T Registry
November 27, 2022
Press release
10 November Conference: Health Innovation – the European Health Data Space and Real-World Evidence
November 24, 2021
Towards Establishing an EU Real-World Evidence Generation Action Plan for Better Healthcare Systems & Patient Outcomes
November 3, 2021
Report
RWE4Decisions workshop report 2021 – Implementing Outcomes Based Managed Entry Agreements – 10 Actions
October 27, 2021
Report
The Use of Real-World Evidence for Decision-Making: Next Steps to Develop HTA Guidance
September 28, 2021
Delivering a Health Data Strategy for the European Reference Networks: Developing a Shared Vision with All Stakeholders
April 22, 2021
Co-Creating Real-World Evidence Excellence for Decision-Making: Meeting Regulatory and HTA/Payer Needs
Contact us if you want to participate
For more information or to participate in an upcoming roundtable, contact the Secretariat.